Search or
𝛼SK
𝛼SKbearish
Quiddity Leaderboard Hang Seng Biotech Sep25: 20 Deletions Likely Due to Major Methodology Change
701 Views17 Jul 2025 19:20
A recent methodology change will result in a drop in constituent count from 50 to 30. This would trigger 20 deletions. These expected DELs could underperform the index over the next few weeks.
What is covered in the Full Insight:
- Introduction to HSHKBIO Methodology Change
- Eligibility and Selection Criteria
- Review Frequency and Weighting
- Expected Index Changes and Trading Strategy
- Conclusion and Anticipated Market Impact
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- [Quiddity Index] Sep25 HSHKBIO Review Announced; 21 DELs, 1 ADD on Methodology Shift25 Aug 2025
- Quiddity Leaderboard Hang Seng Biotech Sep25: Announcement Soon; MANY DELs Likely!18 Aug 2025
- Quiddity Leaderboard HSCEI Sep25: Final Expectations; One Index Change Possible17 Jul 2025
- Quiddity Leaderboard HSTECH Sep25: Final Expectations; ~US$1.6bn One-Way; Long Up 9% Vs Peers17 Jul 2025
- Quiddity Leaderboard Hang Seng Biotech Sep25: Three Changes Likely + One Intra-Review Change12 Jun 2025
x